During the past decade, Goodman Eye Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Goodman Eye Center" are "Keratoconus" (2 trials), "Corneal Diseases" (1 trials), "Corneal Ectasia" (1 trials), "Eye Diseases" (1 trials) and "Pellucid Marginal Corneal Degeneration" (1 trials). Many other conditions were trialed in "Goodman Eye Center" in a lesser frequency.

Most popular intervention types in "Goodman Eye Center" are "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "CXLO Corneal Strengthening Solution and UVA Illumination Device" (1 trials) and "PXL-330 Platinum device for crosslinking with Peschke riboflavin solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Goodman Eye Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Goodman Eye Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Goodman Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Goodman Eye Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".